Monday, May 2, 2016

Imprimis Pharmaceuticals Begins Dispensing Lower Cost Alternative to Thiola® New customizable compounded tiopronin delayed-release formulations may significantly reduce costs and the number of pills cystinuria patients take daily

No comments: